This content is relevant for:Medical Biotechnology / Medical Technologies / Healthcare / Pharmaceuticals
As Europe’s largest medical biotech market, Germany continues to attract foreign investment thanks to its many established companies and dynamic start-up sector. Gradian Diagnostics’ recent acquisition of Molzym is a fine example of international matchmaking, facilitated by Germany Trade & Invest.
Looking for inside stories on economic developments? Our magazine Markets Germany covers the latest scoops three times per year.
It contains interesting reports, features, and news about Germany as an investment and technology location.